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DERMATITIS herpetiformis (DH) is an intensely itchy dermatosis of a chronic
nature. Although the lesions most often consist of tense vesicles grouped on the
extensor surfaces of the body, they may also be erythematous, urticarial or papular
and more diffuse. As a result of the intense itch the lesions are excoriated and
frequently present as small crusted areas. Thus other parameters are necessary to
assist in diagnosis.
For many years therapeutic response to sulphones or sulfrapyridine was an
important criterion in diagnosis, while more recently the diagnosis has been
confirmed by the finding of deposits of immunoglobulin A (IgA) in clinically
uninvolved skin. Since gluten sensitive enteropathy occurs in all patients with DH in
varying degrees,' associated villous atrophy in jejunal biopsies has been used as an
additional diagnostic aid. The presence ofa serum antibody to gliadin, a component
ofgluten, has been associated with patients with gluten sensitive enteropathy,2,3 and
we suggest that detection of this antibody may be an additional help in
differentiating patients with DH from patients with other itchy skin conditions and
may in certain cases eliminate the need for a jejunal biopsy sample.
PATIENTS AND METHODS
Patients
During the period April 1976 to December 1980, one hundred and thirty patients
presented at the Skin Department, Belfast City Hospital, with an itchy skin rash.
The age of these patients ranged from 9 years to 86 years with a sex distribution of
70F:60M. Serum and skin biopsy samples were obtained from all the patients for
routine autoantibody screening and immunopathology. The final diagnosis of the
130 patients was based on clinical features and immunopathology. A diagnosis of
DH was based on the clinical appearance of the rash, the response to dapsone, and
the presence of IgA deposits in uninvolved skin. All patients at the time ofsampling
were on a normal diet and not on dapsone therapy.
Biopsy Specimens
Eliptical skin biopsies, excised with a scalpel from uninvolved areas of skin under
local anaesthetic, were obtained from all 130 patients and were snap frozen in liquid
nitrogen. Jejunal biopsies were obtained from 20/130 patients.
Immunopathology andHistopathology
Cryostat sections (5 pm thick) were tested by direct immunofluorescence using
fluorescein isothiocyanate (FITC) conjugated sheep antibodies to human IgG, IgA,
113IgM, C3 and fibrinogen (Wellcome Diagnostics, England). Jejunal biopsies were
stained by haematoxylin and eosin.
SerologicalInvestigations
The sera of the 130 patients were tested for autoantibodies in the IgG, IgA and
IgM classes to nuclei, smooth muscle, gastric parietal cells, mitochondria, thyroid,
reticulin and gliadin.4 Sera were only considered positive for antireticulin antibody
(ARA) ifthe RI fluorescence pattern described by Rizzetto and Doniach5 was seen.
IgG, IgA and IgM class antigliadin antibodies were detected by indirect immuno-
fluorescence, as described by Unsworth et al.6 Serum samples were tested on
cryostat sections of rat composite tissues which had been exposed at room
temperature to an aqueous solution of gliadin (Sigma Chemical Company) (0.1
mg/ml). The sections were first exposed to the patients' sera and after washing in
phosphate buffered saline (PBS) for 30 minutes, they were exposed to FITC-
conjugated sheep antihuman IgG, antihuman IgA and antihuman IgM (Wellcome
Diagnostics, England) for a further 30 minutes. After a further hour's wash, the
slides were mounted in glycerol saline, and were examined with a Leitz immuno-
fluorescent microscope. Those sera with antigliadin activity gave a reticulin pattern
similar to that of the RI fluorescent staining of ARA on rat composite tissues not
pre-treated with gliadin.
RESULTS
Clinical categories
The final clinical assessment of the 130 patients who presented with an itchy skin
is as follows: Prurigo was the most common diagnosis (42/130 patients). Dermatitis
herpetiformis was diagnosed in 26/130 patients and in a further five patients a
diagnosis of DH was thought probable as these patients responded clinically to
dapsone. However, IgA deposits were not detected in biopsies of their uninvolved
skin, and repeat biopsies were not performed. Eczema was the third most common
diagnosis (19/130). Four patients had dermatitis, three each urticaria or
pemphigoid, two each nickel sensitivity or neurodermatitis. There was also one case
each of bullous eruption, myeloid metaplasia, subcorneal pustular dermatosis,
vasculitis, pityriasis lichenoides et varioliformis acuta and acne excoree. A diagnosis
was not made in 15 patients.
Skin immunopathology
In 23/26 patients, whose uninvolved skin contained IgA deposits, the pattern was
papillary while in the remaining three, it was linear in character. Sometimes deposits
of IgM and C3 were also found.
Villous atrophy
Jejunal biopsies were performed in 16 of the 26 patients with DH. There was
significant villous atrophy of the jejunal mucosa in 11/16 of these patients and in 8
ofthese 11 patients AGA was found. Anti-gliadin antibody was not found in the five
patients with DH with normal jejunal mucosa, nor in the group of patients without
deposits of IgA in skin (probable DH) (Table). Normal mucosa was found injejunal
biopsy specimens in 4/5 of these patients.
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Titres ofantibodies to gliadin and to reticulin in immunoglobulin classes G andA
andfindings ofhistopathological examination ofjejunal biopsies in the 26patients
with DH.
Titrea of Titrea of
Patient antibody to antibody to Jejunal
Number gliadin reticulin Villous atrophy
IgG IgA IgG IgA
1
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20
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NDb
+
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+
ND
ND
+
ND
+
ND
ND
ND
ND
ND
a Antibody titre is expressed as a reciprocal of the serum dilution.
b Not done.
Serologicalfindings
The sera of 13/130 patients contained antibody to gliadin in IgG and IgA classes
only, and these patients were all diagnosed as DH. Five patients had AGA in IgA
class; four patients AGA in IgG class and four patients had AGA in both IgA and
IgG classes. In only four of the AGA positive patients was there a corresponding
presence of antireticulin RI antibody (Table). Other autoantibodies detected were
not of significance.
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The variety of skin conditions which present with an itchy skin indicates the need
for simple tests to help in diagnosis. We present evidence that the presence of AGA
in serum may be an additional screening test defining patients with DH in whom
there is marked enteropathy. Antigliadin antibody has been detected in a number of
patients with DH and coeliac disease and its presence is a good indicator of the
degree of gluten sensitivity as expressed by mucosal damage.2 3
In the present study detection of AGA in serum of 50 per cent (13/26) of the
patients in whom DH was diagnosed, and the correlation between the presence of
this antibody and atrophy ofthejejunal mucosa is in agreement with the findings of
Unsworth and his colleagues.2 In all of our patients with AGA, from whom jejunal
biopsies were obtained, villous atrophy was found.
In the five patients who were diagnosed as "probable" DH, IgA deposits were not
found in uninvolved skin, although they did have a characteristic skin rash which
responded to dapsone. Fry and Seah7 have stated that more than one biopsy may be
needed if IgA deposits are to be found. It is interesting to note that neither AGA nor
ARA was detected in these patients, and in those from whom jejunal biopsies were
obtained, the mucosa was normal.
Antigladin antibodies are not specific for patients with DH and they have been
reported in a percentage of patients with other intestinal conditions such as coeliac
disease, transient gluten intolerance, cow's milk sensitive enteropathy, Crohn's
disease and ulcerative colitis.3 6,8 In our series AGA was only found in those patients
with DH and this is probably due to the fact that none of the other patients had
clinical evidence of intestinal disease.
Antigliadin antibody in the IgA class has been reported to be a sensitive indicator
of severe gluten sensitivity in patients with coeliac disease, and appears to be most
likely to be found in this condition.3 However, in patients with DH we have found
AGA in both IgG and IgA classes in association with villous atrophy.
In this investigation, AGA were only found in patients with DH who had
associated atrophy of their jejunal mucosa, and therefore the presence ofAGA may
be a useful additional test for the diagnosis of patients with DH who have marked
gluten enteropathy and may eliminate the need for ajejunal biopsy in these patients.
The presence of AGA may also be useful to monitor the effectiveness of a gluten-
free diet in patients with DH.
SUMMARY
During the period April 1976 to December 1980, 130 patients presented at the Skin
Department, Belfast City Hospital, complaining ofan itchy dermatosis suggestive of
dermatitis herpetiformis. Twenty-six of these patients were finally diagnosed as
having dermatitis herpetiformis (DH) on the basis of the response of the rash to
dapsone and the presence of IgA deposits in uninvolved skin. Antibodies to gliadin
(AGA) were detected in 13 of these patients and in those patients from whom a
jejunal biopsy was taken, the presence of AGA correlated with villous atrophy. We
report that the presence of AGA may be of additional help in the diagnosis of DH
and may, in certain cases, eliminate the need for jejunal biopsy.
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